Kinetics and involvement of interleukin-17 in the outcome of peritonitis in nondiabetic patients undergoing peritoneal dialysis

Journal of the Chinese Medical Association

Volumn 74, Issue 1, 2011, Pages 11-15

  Wang, Hsin Hui ^a,b   Lee, Tzong Yann ^c,d   Lin, Ching Yuang ^e,f  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

IL 17; Outcome; Peritoneal dialysis; Peritonitis

Indexed keywords

INTERLEUKIN 17;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; EFFLUENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; KINETICS; MALE; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PERITONITIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; KINETICS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; TREATMENT OUTCOME;

EID: 79551503882     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.01.002     Document Type: Article

References (30)

1. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 1998, 9:1956-1964.
2. Fried L.F., Bernardini J., Johnston J.R., Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996, 7:2176-2182.
3. Tranaeus A., Heimburger O., Lindholm B. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): diagnostic findings, therapeutic outcome and complications. Perit Dial Int 1989, 9:179-190.
4. Holley J.L., Bernardini J., Johnston J.R., Piraino B. Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program. Am J Kidney Dis 1990, 16:142-146.
5. Kavanagh D., Prescott G.J., Mactier R.A. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004, 19:2584-2591.
6. Bunke C.M., Brier M.E., Golper T.A. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997, 52:524-529.
7. Keane W.F., Comty C.M., Verbrugh H.A., Peterson P.K. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int 1984, 25:539-543.
8. Wang H.H., Lin C.Y., Huang T.P. Patterns of CD4/CD8 T-cell ratio in dialysis effluents predict the long-term outcome of peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2003, 18:1181-1189.
9. Wang H.H., Lin C.Y. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response. Am J Kidney Dis 2005, 46:328-338.
10. Wang H.H., Lee T.Y., Lin C.Y. Integrins mediate adherence and migration of T lymphocytes on human peritoneal mesothelial cells. Kidney Int 2008, 74:808-816.
11. Holmes C.J. Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int Suppl 1994, 48:S58-S70.
12. Topley N. The cytokine network controlling peritoneal inflammation. Perit Dial Int 1995, 15:S35-S39. discussion S9-S40.
13. Zemel D., Imholz A.L., de Waart D.R., Dinkla C., Struijk D.G., Krediet R.T. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994, 46:1422-1430.
14. Lai K.N., Lai K.B., Lam C.W., Chan T.M., Li F.K., Leung J.C. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000, 35:644-652.
15. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996, 183:2593-2603.
16. Yao Z., Painter S.L., Fanslow W.C., Ulrich D., Macduff B.M., Spriggs M.K., et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995, 155:5483-5486.
17. Jovanovic D.V., Di Battista J.A., Martel-Pelletier J., Jolicoeur F.C., He Y., Zhang M., et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998, 160:3513-3521.
18. Bai H., Cheng J., Gao X., Joyee A.G., Fan Y., Wang S., et al. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 2009, 183:5886-5895.
19. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
20. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007, 8:1390-1397.
21. Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., et al. Preferential recruitment of interferon-gamma-expressing T H 17 cells in multiple sclerosis. Ann Neurol 2009, 66:390-402.
22. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007, 204:1849-1861.
23. Witowski J., Pawlaczyk K., Breborowicz A., Scheuren A., Kuzlan-Pawlaczyk M., Wisniewska J., et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000, 165:5814-5821.
24. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999, 162:2347-2352.
25. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009, 132:3329-3341.
26. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
27. Boniface K., Blom B., Liu Y.J., de Waal Malefyt R. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev 2008, 226:132-146.
28. Shibata K., Yamada H., Hara H., Kishihara K., Yoshikai Y. Resident Vdelta1+gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007, 178:4466-4472.
29. Chung D.R., Kasper D.L., Panzo R.J., Chitnis T., Grusby M.J., Sayegh M.H., et al. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 2003, 170:1958-1963.
30. Ye P., Garvey P.B., Zhang P., Nelson S., Bagby G., Summer W.R., et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 2001, 25:335-340.